Peter Clausen - 31 Jul 2025 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
CSO/COO
Signature
/s/ David Jorden, attorney-in-fact
Issuer symbol
AURX
Transactions as of
31 Jul 2025
Net transactions value
+$73,541
Form type
4
Filing time
04 Aug 2025, 09:06:50 UTC
Previous filing
21 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CLAUSEN PETER CSO/COO C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON /s/ David Jorden, attorney-in-fact 04 Aug 2025 0001605411

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURX Common Stock Options Exercise $73,541 +183,853 +31% $0.4000 770,054 31 Jul 2025 Direct
holding AURX Common Stock 3,474 31 Jul 2025 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURX Option to purchase common stock Options Exercise $0 -183,853 -100% $0.000000 0 09 Aug 2018 Common Stock 183,853 $0.4000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.